Dr. Meeks recaps LUGPA panel on optimizing advanced bladder cancer clinic

"There's 3000 patient trials that are either done or going to be done within the next year or 2 in the BCG-naïve setting, and all of them have systemic therapy," says Joshua J. Meeks, MD, PhD.

Joshua J. Meeks, MD, PhD, is an associate professor of urology at the Northwestern University Feinberg School of Medicine in Chicago, Illinois. In this interview, Meeks recaps a panel discussion on ABCC optimization, which took place at the 2022 LUGPA Annual Meeting in Chicago.